Buy Challenger, not Suncorp

Taking advantage of the baby boom has never been easier.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australian insurance stocks have produced stellar results in the past year thanks to a lack of catastrophe weather events like floods, bushfires and cyclones. Suncorp (ASX: SUN) and Insurance Australia Group (ASX: IAG) have both come out in the past fortnight and provided strong guidance to the market on full-year results.

On Wednesday, Suncorp reported a strong final dividend of 35 cents plus a 20 cent special dividend. However, its bad bank loan sale to Goldman Sachs has caught the market by surprise and investors sold its stocks down almost 3% yesterday. Current prices have built in a higher earnings ratio and it seems investors are expecting solid results in the next two years.

However for this Fool, the stocks are still too expensive to justify a buy. With tougher budgeting requirements for insurance companies operating in Queensland and Australia in general, the certain uncertainty is something I'm not willing to gamble on. The high price, inherent risk associated with insurance stocks and uncertain long term outlook means that Suncorp will remain on the watchlist for now.

A better alternative?

In the half year to 31 December 2012 Challenger (ASX: CGF), an ASX-listed investment management firm that focuses on financial security for retirees, said that by 2030 baby boomers will represent 69% of the retirement population in Australia. We can already see today that Australians are living longer and requiring care and long-term financial security well into retirement.

In addition, Australia's superannuation has recovered from its pre-GFC levels and surpassed the $1.5 trillion level. This is expected to increase to over $6 trillion by 2030.

Challengers operates two core investment businesses, an APRA regulated life division and a fiduciary Funds management division. As such, stock prices for companies such as Challenger, AMP (ASX: AMP) and Perpetual (ASX: PPT) are highly leveraged to the stock markets. In the past 12 months, Challenger is up 25%, slightly ahead of the S&P/ASX 200's (ASX: XJO) (Index: ^AXJO) 20%.

sun
Source: Google Finance

Value

In its most recent half year report the company announced a 17% increase in NPAT and confirmed Challenger's ideal position for the beginning of a 20-year period in which the number of wealthy retirees will increase. However, share prices have lagged.

The company has a market cap of $2.2 billion, $40 billion of FUM, P/E of 7.5 and pays a dividend of 4.5%. Morningstar predicts modest increases in EPS and DPS in the next three years.

Foolish takeaway

In July UBS and Morningstar upgraded their ratings on Challenger. Suncorp's medium-term outlook looks good, however the shares are fairly priced for any growth. Unless the market presents an opportunity to buy the stock on slightly less multiples, this investor will prefer its smaller rival.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Owen Raszkiewicz owns shares in Challenger.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »